David Moadel

David Moadel

InvestorPlace Contributor

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

Is Nio Stock on the Road to Recovery?

By David Moadel, InvestorPlace Contributor

There’s no arguing that NIO stock is incredibly risky. However, with stabilizing delivery numbers and an ultra-low stock price, shares may be suitable for gamblers.

Nvidia Stock Has Value Way Beyond the Limits of Its GPUs

By David Moadel, InvestorPlace Contributor

NVDA stock is far from cheap, but multiple revenue streams suggest there's more upside ahead.

Sooner or Later, Expect Hypergrowth by Salesforce Stock

By David Moadel, InvestorPlace Contributor

Investors should stick with CRM stock because the focus by CRM on privacy will boost Salesforce stock.

Prepare for Cannabis’ Second Act and Hold Your Aphria Shares

By David Moadel, InvestorPlace Contributor

Solid financing and the implementation of Cannabis 2.0 will drive Aphria's growth in 2020's first half.

Hexo? Heck No! Just Avoid Hexo Stock for Now

By David Moadel, InvestorPlace Contributor

I'm still bullish on marijuana stocks, but I won't let Hexo stock weigh down my portfolio.

Load More